View eBook


Welcome to this latest GEN eBook, a publication providing you

Evotec November 2023 eBook coverwith insights into Evotec and our capabilities. This edition features Evotec’s PanOmics-driven drug discovery approach, the impact of precision medicine approaches, and the software platform PanHunter, which is designed to drive enhanced understanding to accelerate the fight against disease. PanHunter is a multi-omics data analysis platform that enables our partners and teams to achieve outstanding research insights and increase the probability of success throughout the entire drug discovery process. With hundreds of dedicated researchers and PanHunter users we have a long and successful history of applying and evolving advanced systems to support our research throughout the value chain from target ID to clinical studies.

Evotec’s collaborations allow us to gain outstanding experience in deriving disease understanding, molecular patient profiles and qualify compounds early. Such models cover challenges such as tox prediction and reach out toward patient stratification and diagnostics. These efforts converged into the release of our software-as-a-service platform that empowers our partners to run large scale multiomics data analysis projects at ease and will give researchers a highly interactive and powerful tool to excel further.

We hope you enjoy reading this GEN eBook and we welcome your thoughts and input. We look forward to the possibility of collaborating with you in this exciting field of multi-omics, AI-driven medicine of the future.


  Sponsored by:

Evotec logo

Previous articleAlzheimer’s APOE4-Linked Pathology May Be Reduced by APOE-R136S Mutation
Next articleOrganoids Evolve from Academic Marvel to Industrial Tool